Grants for Small Businesses

This program provides $5,000 to eligible Worcester-based businesses seeking certifications as Minority-Owned, Women-Owned, or Veteran-Owned through the Massachusetts Supplier Diversity Office.

The Fund Her Future grant program, administered by Block Advisors by H&R Block, offers a total of $100,000 in grants to support the growth of women-owned businesses. This initiative aims to address the funding disparities faced by women, one of the fastest-growing segments of new small business owners. One grand prize winner will receive $50,000, with additional finalists receiving $12,500 each. Alongside monetary awards, winners will also benefit from professional services including small business taxes, bookkeeping, payroll, and business structure analysis. Applications are accepted until May 26, 2024.

The FY24 DMDRP CTRA mechanism supports advanced translational research that will accelerate the movement of promising ideas in DMD research into clinical applications. Translational research may be defined as an integration of basic science and clinical observations. However, applicants should not view translational research as a one-way continuum from bench to bedside. The research plan must involve a reciprocal flow of ideas and information between applied and clinical research. As such, applications must include preliminary and/or published data relevant to DMD to support the proposed research project.This mechanism is intended to support established projects that have moved beyond the realm of basic research and proof of concept studies and have the potential to result in a near-term impact in clinical research or the clinic. Research projects investigating therapies that will be efficacious across the life span, including infants, toddlers, and non-ambulatory individuals, are strongly encouraged. Pilot, proof-of-principle clinical trials, and correlative studies to better inform development of drugs, devices, and other interventions are allowed.Early-Career Partnering PI Option: The FY24 DMDRP encourages applications that include meaningful and productive collaborations between investigators. In an effort to promote enhanced research capacity within the DMD field, the FY24 CTRA includes an option for an Early-Career Partnering Principal Investigator (PI). The Partnering PI Option is structured to accommodate two PIs. One PI will be identified as the Initiating PI and will be responsible for the majority of the administrative tasks associated with application submission. The Early-Career PI will be identified as the Partnering PI. Both PIs should contribute significantly to the development and execution of the proposed research project. If recommended for funding, each PI will be named on separate awards to the recipient organization(s). Each award will be subject to separate reporting, regulatory, and administrative requirements. For individual submission requirements for the Initiating and Partnering PI, refer to Section II.D.2, Content and Form of the Application Submission.The FY24 DMDRP CTRA offers two funding levels (refer to Section II.D.5 Funding Restrictions). Only one funding level category may be chosen per application, and the choice of application category is at the discretion of the applicant. The following are generalized descriptions of the scope of the research appropriate for each funding level:Funding Level 1: Funding Level 1 is intended to support smaller, less complex preclinical and/or clinical research. Pilot clinical trials are allowed. The proposal/applications direct costs budgeted for the entire period of performance should not exceed $650,000.Funding Level 2: Funding Level 2 is intended to support larger, more complex preclinical and/or clinical research. Pilot clinical trials are allowed. The proposal/applications direct costs budgeted for the entire period of performance should not exceed $1.35M.Additionally, both funding levels will support an Early-Career Partnering PI Option at the same maximum direct costs and periods of performance, respectively.For the purposes of this funding opportunity, research that meets the definition of a clinical trial is distinct from clinical research. Both pilot clinical trials and clinical research are permitted under this mechanism.A clinical trial is defined in the Code of Federal Regulations, Title 45, Part 46.102 (45 CFR 46.102) as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include a placebo or another control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes.Studies that do not seek to measure safety, effectiveness, and/or efficacy outcome(s) of an intervention are not considered clinical trials.Clinical research encompasses research with human data, human specimens, and/or interaction with human subjects. Clinical research is observational in nature and includes:(1) Research conducted with human subjects and/or material of human origin such as data, specimens, and cognitive phenomena for which an investigator (or co-investigator) does not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention. Research meeting this definition may include but is not limited to: (a) mechanisms of human disease, (b) diagnostic or detection studies (e.g., biomarker or imaging), (c) health disparity studies, and (d) development of new technologies.(2) Epidemiologic and behavioral studies that do not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention.(3) Outcomes research and health services research that do not fit under the definition of clinical trial.Excluded from the definition of clinical research are in vitro studies that utilize human data or specimens that cannot be linked to a living individual and meet the requirements for exemption under 46.104(d)(4) of the Common Rule.All investigators applying to FY24 DMDRP funding opportunities and conducting clinical research are encouraged to consult the Strategies to Promote Diversity in Muscular Dystrophy Research Participation developed by the MDCC.

The FY24 DMDRP IDA promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports conceptually innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with DMD. Applications should include a well-formulated, testable hypothesis based on strong scientific rationale.New Investigators: The FY24 DMDRP IDA mechanism encourages applications from independent investigators in the early stages of their careers (i.e., within 10 years of their first faculty appointment or equivalent) or applications from established investigators new to DMD research.The New Investigator Early Stage category is designed to allow applicants early in their faculty appointments to compete for funding separately from established investigators.The New Investigator Transitioning category is designed to allow investigators in an area other than muscular dystrophy, at or above the level of Assistant Professor, seeking to transition to a career in DMD, thereby bringing their expertise to the field.Applications from New Investigators and Established Investigators will be peer and programmatically reviewed separately. Principal Investigators (PIs) using the New Investigator Early Stage category or New Investigator Transitioning category are strongly encouraged to strengthen their applications by collaborating with investigators experienced in DMD research and/or possessing other relevant expertise. It is the responsibility of the applicant to describe how the included collaboration will augment the PIs expertise to best address the research question. All applicants for the New Investigator categories must meet the specific eligibility criteria described in Section II.C, Eligibility Information.Preliminary data relevant to DMD that supports the feasibility of the research hypotheses and research approaches are required. Preliminary data may include unpublished results from the laboratory of the PI, research team or collaborators named on the application.Key elements of this award are as follows:Innovation: Research deemed innovative may introduce a new paradigm, challenge current paradigms, look at existing problems from new perspectives, or exhibit other uniquely creative qualities.Impact: Research that has high potential impact may lead to major advancements and significantly accelerate progress toward improving outcomes for individuals with DMD.It is the responsibility of the PI to clearly and explicitly articulate the projects innovation and its potential impact on DMD. The projects impact to both DMD research and to individuals with DMD should be articulated, even if clinical impact is not an immediate outcome. Applications that demonstrate exceptional scientific merit but lack innovation and high potential impact do not meet the intent of the IDA.Clinical trials are not allowed under this funding opportunity.A clinical trial is defined in 45 CFR 46.102 as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include a placebo or another control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes.Studies that do not seek to measure safety, effectiveness, and/or efficacy outcome(s) of an intervention are not considered clinical trials.For the purposes of this funding opportunity, research that meets the definition of a clinical trial is distinct from clinical research. Clinical research encompasses research with human data, human specimens, and/or interaction with human subjects. Clinical research is observational in nature and includes:(1) Research conducted with human subjects and/or material of human origin such as data, specimens, and cognitive phenomena for which an investigator (or co-investigator) does not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention. Research meeting this definition may include but is not limited to: (a) mechanisms of human disease, (b) diagnostic or detection studies (e.g., biomarker or imaging), (c) health disparity studies, and (d) development of new technologies.(2) Epidemiologic and behavioral studies that do not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention.(3) Outcomes research and health services research that do not fit under the definition of clinical trial.Excluded from the definition of clinical research are in vitro studies that utilize human data or specimens that cannot be linked to a living individual and meet the requirements for exemption under 46.104(d)(4) of the Common Rule.

This funding opportunity is designed for organizations that provide accredited medical education to healthcare professionals, ensuring their programs meet ethical standards and enhance professional development in specific therapeutic areas.

The PRP IIRA supports highly rigorous, multidisciplinary, high-impact research projects that have the potential to make an important contribution to Parkinsons research. This award mechanism supports the full spectrum of research from basic science through clinical research.

With this solicitation, OVC seeks to award a 36-month cooperative agreement to one lead organization that will (1) fund (through a competitive process) subawards to communities severely affected by violence to establish trauma recovery centers , and (2) provide technical assistance to the subawardees to support operation of the centers. The trauma recovery centers funded under this demonstration project will address crime victimization and support access to victims compensation, crime victims rights enforcement, trauma recovery, and healing. Subawardees will be expected to design centers to provide services to crime victims who traditionally do not seek victims services, assistance, or counseling, or are historically underserved. This demonstration is intended to span 5 years (60 months total) via an initial 3-year budget allocation under this solicitation, with the potential for noncompetitive continuation funding as the project moves from year 3 to year 5 of its implementation.

The Make it Minnesota Marketing Investment Cost-Share Program, funded by the Minnesota Department of Agriculture's AGRI Program, supports Minnesota-based consumer packaged goods (CPG) companies in food, beverage, or pet food sectors. The program reimburses 50% of eligible marketing investments up to a maximum of $3,000 per company per fiscal year. This funding can be used for in-store demonstrations, Minnesota Pavilion events, and B2B tradeshow costs, among other high-impact marketing activities. The program aims to help these companies increase their market presence both domestically and internationally.

This track of the Resilient Food Systems Infrastructure (RFSI) program provides approximately $1 million for grants aimed at purchasing equipment necessary for the middle of the food supply chain activities in Vermont. The grants range from $30,000 to $100,000 with no match requirement. Applications for this track are set to open in late August 2024 and close in early October 2024, with grant activities beginning in early 2025.

The Resilient Food Systems Infrastructure (RFSI) program, funded by the USDA, allocates approximately $2 million for infrastructure grants to Vermont businesses and organizations aiming to strengthen local and regional food systems. The grants support projects that improve the aggregation, distribution, manufacturing, processing, storing, transporting, and wholesaling of Vermont food products. This track encourages development of Vermont value-added products and promotes fair wages and job creation. A 50% match is required, which can be reduced to 25% for historically underserved farmers. Grants range from $100,000 to $500,000 and are available from fall 2024 through February 2027.

The Goshen County Tourism Promotion Joint Powers Board [a.k.a. Goshen County Lodging Tax Board] is dedicated to enhancing travel and tourism across Goshen County. The board's initiatives focus on creating effective marketing strategies to promote the area as a travel destination. They have set aside approximately $321,000.00 for the Tourism Sponsorship Program, which grants funds to event organizers. These events are aimed at promoting local, regional, and national public relations efforts that bring both visitors and residents to Goshen County. Applicants need to demonstrate that their events can attract tourists and support the local tourism sector. The funding is reimbursed based on actual expenses reported after the event. Applications are due one the first Tuesday of January, April, July and October

CSO announces an open competition for organizations interested in submitting applications for programs that support increasing the capacity of a cohort of civil servants within the Republic of Yemen Government (ROYG) to identify priorities for the development of inclusive stabilization plans.

This funding opportunity supports research to implement and evaluate a fall prevention program for older adults in assisted living facilities, particularly targeting vulnerable populations at higher risk of falls.

The Economic Development Fund, supported by the East Tennessee Foundation, is designed to advance regional economic development through charitable and educational programs. This grant program directly aligns with the foundation's mission by fostering economic growth and stability within selected counties of Tennessee. The foundation's strategic priority is to invest in initiatives that contribute to the long-term well-being and prosperity of the region, utilizing a theory of change that posits that targeted support for economic and educational programs will lead to a more vibrant and sustainable local economy. The program targets 501(c)(3) public charities, units of government, and public educational institutions. New or emerging groups without nonprofit status can apply with a fiscal sponsor. The ideal beneficiaries are organizations that demonstrate a commitment to non-discrimination, ensuring that their projects do not exclude individuals based on race, color, national origin, religion, gender, familial status, sexual orientation, age, disability, or veteran status. The impact goals are centered on strengthening the economic infrastructure and educational opportunities within the community. The fund prioritizes projects that contribute to regional economic development, with a particular focus on programs that align with the foundation’s commitment to diversity and inclusion. While faith-based organizations are welcome to apply, their projects must not have explicit religious content, express a particular religious view, limit participation based on faith affiliation, or require participation in religious activities or services. This ensures that the grants support broadly accessible community-focused initiatives. Expected outcomes include enhanced economic activity, increased educational attainment, and a more robust regional economy. Measurable results will be assessed through the one-year grant term, from August 1, 2024, to July 31, 2025. The grants, ranging from $5,000 to $6,500, are intended to provide meaningful support for projects that can demonstrate tangible progress within this timeframe. The foundation expects to see clear evidence of how the funding has contributed to the stated economic development and educational goals.

This program provides forgivable loans to small businesses, nonprofits, and developers in Los Angeles County to acquire and revitalize under-utilized commercial properties, fostering community-serving spaces and promoting equitable economic development.

This program provides financial support to Worcester-based minority, women, veteran, LGBTQ+, and disability-owned businesses that achieve certification with the Massachusetts Supplier Diversity Office, prioritizing those from disproportionately impacted communities.

This grant provides financial assistance to local organizations for printing promotional brochures that highlight attractions in Dodge City, aiming to increase tourism and visibility for overnight visitors.

The City of West Hollywood's Arts Project Grant offers funding to eligible nonprofit arts organizations for projects taking place within the city and serving its community. This program aligns with the city's broader mission to enrich the lives of its residents and visitors through cultural engagement. The grant aims to foster a vibrant arts scene, recognize and champion local cultural resources, and discover new places for artmaking, directly supporting the city's commitment to cultural development and community well-being. The primary target beneficiaries are the residents and visitors of West Hollywood, with a focus on increasing their access to quality arts programming. The program seeks to engage diverse audiences and expand participation in the arts, particularly making experiences financially and geographically accessible. Beyond cultural enrichment, the grant also intends to support local businesses by increasing revenues and fostering arts-business partnerships, contributing to the economic vitality of the West Hollywood community. Key priorities for this grant include presenting one artistic presentation per year, as opposed to a series of projects, ensuring focused and impactful events. The program prioritizes organizations that can demonstrate artistic experience, an understanding of West Hollywood's unique cultural diversity, and a commitment to serving the general public within the city or immediately adjacent areas. Projects that do not include fundraisers, capital campaigns, murals, or religious-based programs are eligible, maintaining a clear focus on public arts presentations. Expected outcomes and measurable results are centered on increasing engagement with the arts, expanding arts audiences, and enhancing the accessibility of arts experiences for West Hollywood residents. The program also aims to strengthen local cultural resources and generate economic benefits for local businesses through arts-related activities. While specific quantitative metrics are not detailed in the provided text, the emphasis on "increasing access," "expanding audiences," and "increasing revenues for local businesses" indicates the desire for demonstrable positive impacts in these areas. The City of West Hollywood's strategic priorities for this grant reflect a theory of change that postulates that by investing in local arts organizations and projects, the city can foster a more engaged, culturally rich, and economically robust community. The grant's focus on accessibility, local relevance, and partnership building suggests a belief that widespread participation in the arts can lead to a stronger sense of community, increased quality of life for residents, and tangible economic benefits for local enterprises. This aligns with a broader strategy of leveraging cultural assets for comprehensive community development.

The City of Hyattsville Vandalism Prevention Grants Program aims to offer financial relief to small businesses and 501(c)(3) non-profit organizations within Hyattsville that have been negatively affected by vandalism. This program is funded through the American Rescue Plan Act (ARPA) and has a total of $15,000 available, split between two grants. The Vandalism Prevention Grant is specifically a reimbursement grant. While a direct "foundation mission alignment" and "theory of change" from the City of Hyattsville are not explicitly stated, the program's existence clearly aligns with a municipal mission to support local economic stability and community safety by mitigating the financial burdens of vandalism on its small business and non-profit sectors. The primary target beneficiaries are small businesses and 501(c)(3) non-profit organizations located in Hyattsville. A small business is defined as having fewer than 50 employees, annual revenues between $1,000 and $5 million, being independently owned and operated, and not dominant in its field. Franchise owners are eligible, but private residences, landlords, and multifamily residential properties are excluded. The impact goal is to help these entities cover costs associated with eligible repairs and security measures following vandalism incidents, thereby fostering their recovery and enhancing their resilience against future occurrences. The program prioritizes funding for specific eligible security measures. These include security cameras and recording equipment, shatterproof glass and protective films, lock enhancements, exterior lighting enhancements, alarm and monitoring systems, and anti-graffiti films, paints, or coatings. Funds are provided as a reimbursement for these measures acquired between July 1, 2022, and June 30, 2024. The focus is clearly on proactive and reactive measures that directly address the physical and financial impacts of vandalism. The expected outcomes include reduced financial strain on affected small businesses and non-profits, improved security infrastructure across the city's commercial and non-profit sectors, and a disincentive for future vandalism through enhanced protective measures. Measurable results would be tracked by the number of grants awarded, the total amount of funds reimbursed, and the types of security measures implemented. While the document does not outline specific metrics like "reduction in vandalism incidents," the direct correlation between funding security enhancements and mitigating vandalism effects implies these as indirect, desired outcomes. The maximum award for the Vandalism Prevention Grant is $2,000 per business or non-profit organization.

The CDC Foundation is offering a grant program to community-based organizations (CBOs) focused on raising awareness about critical health warning signs during and after pregnancy. This initiative is part of the national "Hear Her" communication campaign, which aims to improve communication among pregnant and postpartum individuals, their support networks, and healthcare providers. The program aligns with the CDC Foundation's mission to protect health and safety by supporting public health initiatives, specifically addressing maternal health outcomes, which is a key strategic priority. The primary target beneficiaries of this grant are pregnant and postpartum people, along with their support networks (friends and family) and healthcare providers who interact with this population. The impact goal is to educate communities and improve communication, ultimately leading to better maternal health outcomes. Organizations serving communities that experience poorer maternal health outcomes are a particular focus. The program prioritizes CBOs that are headquartered in and serve communities within the US. Eligible organizations must specifically serve pregnant or postpartum people, their support systems, and/or healthcare providers. A key focus is on organizations with the staff capacity to execute planned activities within the one-year grant duration and those that serve their local communities. Special consideration is given to organizations serving specific metropolitan areas, including Atlanta, Dallas/Ft. Worth, New Orleans, New York City, and St. Louis, as well as those whose leadership and staff reflect the communities they serve. The expected outcome of this grant program is increased awareness of important health warning signs during and after pregnancy among the target population. Measurable results will stem from the successful implementation of activities designed to educate communities and enhance communication. By fostering better communication and awareness, the CDC Foundation's theory of change suggests that individuals will be empowered to recognize and act on warning signs, leading to timely interventions and a reduction in adverse maternal health events. The program offers up to six awards of $50,000 each, with activities to be completed within one year.